May 2007
Volume 48, Issue 13
ARVO Annual Meeting Abstract  |   May 2007
Patient-Reported Barriers to Glaucoma Medication Access, Use, and Adherence in Southern India
Author Affiliations & Notes
  • M. Cho
    Ophthalmology, New York Universtiy School of Medicine, New York, New York
  • B. L. Sleath
    Cecil G. Sheps Center for Health Services Research, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina
  • R. Krishnadas
    Aravind Medical Research Foundation, Aravind Eye Care System, Madurai, India
  • A. L. Robin
    Ophthalmology and International Health, Johns Hopkins University and University of Maryland School of Medicine, Baltimore, Maryland
  • Footnotes
    Commercial Relationships M. Cho, None; B.L. Sleath, None; R. Krishnadas, None; A.L. Robin, None.
  • Footnotes
    Support None.
Investigative Ophthalmology & Visual Science May 2007, Vol.48, 5581. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      M. Cho, B. L. Sleath, R. Krishnadas, A. L. Robin; Patient-Reported Barriers to Glaucoma Medication Access, Use, and Adherence in Southern India. Invest. Ophthalmol. Vis. Sci. 2007;48(13):5581.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Purpose:: The purpose of the study were: (a) to describe the different types of problems that patients in relatively rural southern India reported having when taking their glaucoma medications and (b) to examine the relationship between patient reported-problems in taking their glaucoma medications and self-reported patient adherence.

Methods:: A validated survey was administered by clinic volunteers to 243 glaucoma patients who were on at least one glaucoma medication in an eye clinic in southern India. We calculated average percent adherence to glaucoma medications for each patient.We used logistic regression to examine how patient characteristics and problems in using glaucoma medications were related to reported adherence.

Results:: We found that 42% of patients reported one or more problems in using their glaucoma medications. Seventeen percent of patients reported that it took them more than one hour to get to their pharmacy. Six percent of patients reported being less than 100% adherent to their glaucoma medications in the past week. Patients who reported more problems in using their glaucoma medications were significantly more likely to report non-adherence.

Conclusions:: Ophthalmologists should make sure to discuss the problems/concerns that patients may have in taking their glaucoma medications in an effort to improve adherence. Adherence to medications might be considered an important consideration within Vision 2020's initiative to eliminate global blindness.

Keywords: clinical (human) or epidemiologic studies: treatment/prevention assessment/controlled clinical trials 

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.